Markets:

Overview

News

Currencies

International

Treasuries

Blueprint Medicines Corporation - Common Stock (NQ:BPMC)

129.46 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Blueprint Medicines Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗

August 22, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.

Via Benzinga

Blueprint Medicines' Ayvakit 'Will Garner Approval' Despite Questions, This Analyst Says ↗

August 18, 2022

Via Benzinga

Analyst Sees Deteriorated Treatment Effect Of Blueprint's Much Awaited Mastocytosis Data ↗

August 17, 2022

Via Benzinga

Data From Blueprint Medicines' Blood Disorder Trial Fails To Lift Shares ↗

August 17, 2022

Blueprint Medicines Corporation (NASDAQ: BPMC)

Via Benzinga

Where Blueprint Medicines Stands With Analysts ↗

August 03, 2022

Within the last quarter, Blueprint Medicines (NASDAQ:BPMC) has observed the following analyst ratings:

Via Benzinga

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

Blueprint Medicines: Q2 Earnings Insights ↗

August 02, 2022

Blueprint Medicines (NASDAQ:BPMC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

4 Analysts Have This to Say About Blueprint Medicines ↗

June 10, 2022

Blueprint Medicines (NASDAQ:BPMC) has observed the following analyst ratings within the last quarter:

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 17, 2022

Via Benzinga

Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday ↗

August 17, 2022

Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.

Via Benzinga

U.S. Stocks Open Lower; Nasdaq Down 150 Points ↗

August 17, 2022

U.S. stocks traded lower this morning, with the Nasdaq composite dropping more than 150 points on Wednesday.

Via Benzinga

Blueprint Medicines Stock Is Getting Hammered Wednesday: What's Happening? ↗

August 17, 2022

Blueprint Medicines Corp (NASDAQ: BPMC) shares are trading lower by 22.2% to $53.32 Wednesday morning after the company announced top-line results from the registrational Part 2 of the PIONEER clinical...

Via Benzinga

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗

August 17, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...

Via Benzinga

Blueprint Medicines Stock Hammered As 'Long-Awaited' Test Results Disappoint ↗

August 17, 2022

Blueprint Medicines met all its goals, but the results paled from an earlier study.

Via Investor's Business Daily

Blueprint Medicines Shares Fall After Topline Results From Late-Stage Neoplastic Disorder Study ↗

August 17, 2022

Blueprint Medicines (NASDAQ: BPMC) announced positive top-line results from the Part 2 of PIONEER clinical trial of AYVAKIT (avapritinib) in patients with non-advanced systemic mastocytosis (SM).

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 17, 2022

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Preview Of Blueprint Medicines's Earnings ↗

August 01, 2022

Blueprint Medicines (NASDAQ:BPMC) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

3 Biotech Stock Picks From This Wedbush Analyst ↗

July 27, 2022

While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June.

Via Benzinga

Week In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology Investments ↗

July 16, 2022

Qiming Venture Partners closed two new China healthcare and technology funds with $3.2 billion in fresh capital, both of them at their hard cap limits. The USD Fund VIII has $2.5 billion and the first...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗

July 08, 2022

Via Benzinga

This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation' ↗

June 30, 2022

Via Benzinga

What 7 Analyst Ratings Have To Say About Blueprint Medicines ↗

June 27, 2022

Within the last quarter, Blueprint Medicines (NASDAQ:BPMC) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022 ↗

June 27, 2022

Upgrades

Via Benzinga

SVB Leerink Maintains Market Perform Rating for Blueprint Medicines: Here's What You Need To Know ↗

June 13, 2022

SVB Leerink has decided to maintain its Market Perform rating of Blueprint Medicines (NASDAQ:BPMC) and lower its price target from $82.00 to $60.00. Shares of Blueprint Medicines are trading down 8.32%...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 13, 2022

RBC Capital reduced Tesla, Inc. (NASDAQ: TSLA) price target from $1,175 to $1,100. Tesla shares fell 3.7% to $670.89 in pre-market trading.

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

44 Stocks Moving In Friday's Mid-Day Session ↗

June 10, 2022

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2022 ↗

June 10, 2022

Via Benzinga

What You Missed On Wall Street On Thursday ↗

June 10, 2022

Here are our top five lists with the news and calls moving stocks, that you better not have missed yesterday...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Blueprint Medicines Corporation - Common Stock (NQ:BPMC)

Headline News about Blueprint Medicines Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today